Skip to main content
OpenTrials
Completed

NCT Number: NCT02583035

Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy

There are no recommendations and few studies on the monitoring of fragile patients in the oncological treatment, both on the organizational arrangements on its interest in the prevention of functional deterioration of the patient and adaptation of the potential cancer treatment.

The oncogériatrique evaluation being time-consuming, requiring the movement of these more or less frail elderly patients, it seems difficult to envisage repeated and systematic standardized geriatric assessments during cancer treatment. Geriatric fragility can be detected by telephone. Craven et al. has already assessed the telephone follow-up by a nurse in patients treated for cancer, but with the aim to detect toxicities of cancer treatment, patients are not very old (mean age 64.8 years).

External evaluation by the nurse coordinator of UCOG (Coordination Unit in geriatric oncology) not knowing the patients included avoids bias of subjectivity in the interrogation.

However the telephone monitoring, with the aim to evaluate the evolution of geriatric frailty, has not been specifically studied in the elderly population treated for cancer, while taking oncology load.

The investigators wish to study the feasibility and validity of telephone follow-up which could eventually be used routinely to identify patients requiring further medical consultation oncogériatrique.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Hematologic Diseases Hematologic Malignancy Hematologic Neoplasms Hemic and Lymphatic Diseases Neoplasms Neoplasms by Site

Age range

70 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier, Bayeux, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 70 years and older with cancer or hematologic malignancies;
  • Faced benefit from cancer treatment (systemic treatment, curative radiotherapy) in one of the clinical sites;
  • Addressed in onco-gériatric consultation in the usual routine care sector;
  • Mastery of the French language;
  • Patient affiliated to the social security system;
  • Patient has given its written consent.

Exclusion criteria

  • Life expectancy <3 months
  • Inability to communicate by telephone (deafness, speech disorder, ..)
  • Inability collection of written consent
  • Group 4 SiO (International Society of Geriatric Oncology), Performance status (PS) 4
  • initial MMSE (Mini-Mental State Examination) <18/30
  • oncological treatment envisaged: analgesic radiotherapy or exclusive decompressive, brain radiation therapy in toto
  • Patient under guardianship

Treatment and study plan

Nurse telephone contact

Other

Nurse will contact patient 3 days before consultation

Primary outcomes

  1. Memory on the Mini Mental Scale

    Time frame: 3 months after inclusion

  2. Falls on the number of falls

    Time frame: 3 months after inclusion

  3. Pain on the EVS (verbal scale) scale

    Time frame: 3 months after inclusion

  4. Autonomy on the ADL (activities of daily living) score

    Time frame: 3 months after inclusion

  5. Pain on the EN (numericale scale) scale

    Time frame: 3 months after inclusion

  6. Autonomy on the IADL (The Lawton Instrumental Activities of Daily Living Scale ) score

    Time frame: 3 months after inclusion

Sponsors and collaborators

Lead sponsor

Centre Francois Baclesse

Other

Registry information

Acronym: TelOG

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Oct 21, 2015
Registry last updated
Jan 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.